Yacoub Khalaf
Research Subjects
Yacoub Khalaf has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Peter Braude
3 shared publicationsTarek El-Toukhy
3 shared publicationsAlison Taylor
Guy ' s and St Thomas ' Hospital NHS Trust
2 shared publications- Arri Coomarasamy
College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
2 shared publications P. Braude
Assisted Conception Unit and 1 Assisted Conception Unit and 2 Department of Microbiology, Guy’s and St Thomas’s Hospital Foundation Trust, London, UK
2 shared publications- Paul Townsend Seed
Department of Women and Children's Health, King's College London, London, UK
2 shared publications
Latest Publications
- Open Access
- 13 June 2019
- Published by Springer Nature in Reproductive Health
- Vol. 16 (1) , 1-11
Study protocol: E-freeze - freezing of embryos in assisted conception: a randomised controlled trial evaluating the clinical and cost effectiveness of a policy of freezing embryos followed by thawed frozen embryo transfer compared with a policy of fresh embryo transfer, in women undergoing in vitro fertilisation
Infertility affects one in seven couples; many of these need in vitro fertilisation (IVF). IVF involves external hormones to stimulate a woman’s ovaries to produce eggs which are harvested surgically. Embryos, created in the laboratory by mixing eggs with sperm, are grown in culture for a few days before being replaced within the uterus (fresh embryo transfer). Spare embryos are usually frozen with a view to transfer at a later point in time – especially if the initial fresh transfer does not result in a pregnancy. Despite improvements in technology, IVF success rates remain low with an overall live birth rate of 25–30% per treatment. Additionally, there are concerns about health outcomes for mothers and babies conceived through IVF, particularly after fresh embryo transfer, including maternal ovarian hyperstimulation syndrome (OHSS) and preterm delivery. It is believed that high levels of hormones during ovarian stimulation could create a relatively hostile environment for embryo implantation whilst increasing the risk of OHSS. It has been suggested that freezing all embryos with the intention of thawing and replacing them within the uterus at a later stage (thawed frozen embryo transfer) instead of fresh embryo transfer, may lead to improved pregnancy rates and fewer complications. We aim to compare the clinical and cost effectiveness of fresh and thawed frozen embryo transfer, with the primary aim of identifying any difference in the chance of having a healthy baby. E-Freeze is a pragmatic, multicentre two-arm parallel group randomised controlled trial where women aged ≥18 and < 42 years, with at least three good quality embryos are randomly allocated to receive either a fresh or thawed frozen embryo transfer. The primary outcome is a healthy baby, defined as a term, singleton, live birth with appropriate weight for gestation. Cost effectiveness will be calculated from a healthcare and societal perspective. E-Freeze will determine the relative benefits of fresh and thawed frozen embryo transfer in terms of improving the chance of having a healthy baby. The results of this pragmatic study have the potential to be directly transferred to clinical practice. ISRCTN registry: ISRCTN61225414 . Date assigned 29/12/2015.
- 13 June 2019
- Published by Springer Nature in Reproductive Health
- Vol. 16 (1) , 1-11
Open AccessStudy protocol: E-freeze - freezing of embryos in assisted conception: a randomised controlled trial evaluating the clinical and cost effectiveness of a policy of freezing embryos followed by thawed frozen embryo transfer compared with a policy of fresh embryo transfer, in women undergoing in vitro fertilisation
Infertility affects one in seven couples; many of these need in vitro fertilisation (IVF). IVF involves external hormones to stimulate a woman’s ovaries to produce eggs which are harvested surgically. Embryos, created in the laboratory by mixing eggs with sperm, are grown in culture for a few days before being replaced within the uterus (fresh embryo transfer). Spare embryos are usually frozen with a view to transfer at a later point in time – especially if the initial fresh transfer does not result in a pregnancy. Despite improvements in technology, IVF success rates remain low with an overall live birth rate of 25–30% per treatment. Additionally, there are concerns about health outcomes for mothers and babies conceived through IVF, particularly after fresh embryo transfer, including maternal ovarian hyperstimulation syndrome (OHSS) and preterm delivery. It is believed that high levels of hormones during ovarian stimulation could create a relatively hostile environment for embryo implantation whilst increasing the risk of OHSS. It has been suggested that freezing all embryos with the intention of thawing and replacing them within the uterus at a later stage (thawed frozen embryo transfer) instead of fresh embryo transfer, may lead to improved pregnancy rates and fewer complications. We aim to compare the clinical and cost effectiveness of fresh and thawed frozen embryo transfer, with the primary aim of identifying any difference in the chance of having a healthy baby. E-Freeze is a pragmatic, multicentre two-arm parallel group randomised controlled trial where women aged ≥18 and < 42 years, with at least three good quality embryos are randomly allocated to receive either a fresh or thawed frozen embryo transfer. The primary outcome is a healthy baby, defined as a term, singleton, live birth with appropriate weight for gestation. Cost effectiveness will be calculated from a healthcare and societal perspective. E-Freeze will determine the relative benefits of fresh and thawed frozen embryo transfer in terms of improving the chance of having a healthy baby. The results of this pragmatic study have the potential to be directly transferred to clinical practice. ISRCTN registry: ISRCTN61225414 . Date assigned 29/12/2015.
- 2 October 2013
- Published by Springer Nature
- p. 101-109
Managing the PGD Cycle
- Open Access
- 1 March 2013
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 26 (3) , 199-200
Introduction to Evidence-Based Reproductive Medicine Symposium
- 1 March 2013
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 26 (3) , 199-200
Open AccessIntroduction to Evidence-Based Reproductive Medicine Symposium
- Open Access
- 18 January 2013
- Published by Springer Nature
TRansvaginal Ultrasonography versus Saline sonography Trial in patients having their IVF treatment - TRUST-IVF study
- 18 January 2013
- Published by Springer Nature
Open AccessTRansvaginal Ultrasonography versus Saline sonography Trial in patients having their IVF treatment - TRUST-IVF study
- Open Access
- 17 January 2013
- Published by Springer Nature
A randomised controlled trial comparing the Gonadotrophin Releasing Hormone agonist long regimen versus the Gonadotrophin Releasing Hormone agonist short regimen versus the Gonadotrophin Releasing Hormone antagonist regimen in poor responders undergoing in vitro fertilisation treatment
- 17 January 2013
- Published by Springer Nature
Open AccessA randomised controlled trial comparing the Gonadotrophin Releasing Hormone agonist long regimen versus the Gonadotrophin Releasing Hormone agonist short regimen versus the Gonadotrophin Releasing Hormone antagonist regimen in poor responders undergoing in vitro fertilisation treatment
- 31 December 2011
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 23 (6) , 695-696
The search for a practice model to reduce miscarriage after assisted reproduction
- 31 December 2011
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 23 (6) , 695-696
The search for a practice model to reduce miscarriage after assisted reproduction
- 31 October 2011
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 23 (4) , 407-410
Reducing multiple pregnancies after assisted reproduction treatment: Québec says ‘Yes, we can!’
- 31 October 2011
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 23 (4) , 407-410
Reducing multiple pregnancies after assisted reproduction treatment: Québec says ‘Yes, we can!’
- Open Access
- 30 September 2011
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 16 (3) , 187-188
Elective single embryo transfer (eSET) for all patients – Does the end justify the means?
- 30 September 2011
- Published by Springer Nature in Middle East Fertility Society Journal
- Vol. 16 (3) , 187-188
Open AccessElective single embryo transfer (eSET) for all patients – Does the end justify the means?